Moderna SARS-CoV-2 Vaccine (mRNA-1273) Interim Phase 1 Data Conference Call
May 18, 2020 at 8:30 AM EDT
Supporting Materials
×
You are now leaving investors.modernatx.com, a website provided by Moderna. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. The content displayed on external websites is not controlled by Moderna, and Moderna assumes no responsibility for the information or statements on such external websites.